These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11182286)

  • 1. Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome.
    Yiu VW; Kovithavongs T; McGonigle LF; Ferreira P
    Pediatr Neurol; 2001 Jan; 24(1):72-4. PubMed ID: 11182286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis.
    Armstrong MB; Robertson PL; Castle VP
    Pediatr Neurol; 2005 Nov; 33(5):365-7. PubMed ID: 16243225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsoclonus myoclonus syndrome: response to plasmapheresis.
    R SS; Mani PJ
    Indian Pediatr; 2004 May; 41(5):499-502. PubMed ID: 15181303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
    Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
    Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in paraneoplastic opsoclonus-myoclonus syndrome associated with small cell lung cancer.
    Hassan KA; Kalemkerian GP; Trobe JD
    J Neuroophthalmol; 2008 Mar; 28(1):27-30. PubMed ID: 18347455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of cellular immune activation in children with opsoclonus-myoclonus: cerebrospinal fluid neopterin.
    Pranzatelli MR; Hyland K; Tate ED; Arnold LA; Allison TJ; Soori GS
    J Child Neurol; 2004 Dec; 19(12):919-24. PubMed ID: 15704863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.
    Bataller L; Graus F; Saiz A; Vilchez JJ;
    Brain; 2001 Feb; 124(Pt 2):437-43. PubMed ID: 11157570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
    Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
    J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
    Russo C; Cohn SL; Petruzzi MJ; de Alarcon PA
    Med Pediatr Oncol; 1997 Apr; 28(4):284-8. PubMed ID: 9078325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG.
    Pranzatelli MR; Tate ED; Kinsbourne M; Caviness VS; Mishra B
    Mov Disord; 2002 Nov; 17(6):1387-90. PubMed ID: 12465092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease preceded by unique neurological symptoms.
    Shimamura M; Uchida Y; Terasaki T; Hashimoto Y; Yamasaki H; Tsuda H; Wakayama T; Ando T; Uchino M
    Intern Med; 2001 Aug; 40(8):819-21. PubMed ID: 11518134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
    Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic neurological syndromes--diagnosis and management.
    Blaes F
    Curr Pharm Des; 2012; 18(29):4518-25. PubMed ID: 22612756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic results in three cases of ganglioneuroblastoma associated with opsoclonus myoclonus ataxia syndrome.
    Shtarbanov IA; Boronsuzov IK; Chakarov IR; Konstantinov DN
    Indian J Cancer; 2020; 57(2):216-218. PubMed ID: 31898588
    [No Abstract]   [Full Text] [Related]  

  • 16. Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia.
    Turkel SB; Brumm VL; Mitchell WG; Tavare CJ
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):239-41. PubMed ID: 16720803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
    Fine JD; Appell ML; Green LK; Sams WM
    Arch Dermatol; 1988 Feb; 124(2):236-9. PubMed ID: 3277542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy.
    Pranzatelli MR; Chun KY; Moxness M; Tate ED; Allison TJ
    Pediatr Neurol; 2005 Aug; 33(2):121-6. PubMed ID: 16087057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The opsoclonus-myoclonus syndrome].
    de Brabander C; Hoff JI; Tijssen CC; Lammers GJ; Verschuuren JJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):201-4. PubMed ID: 15702740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of ten children with opsoclonus-myoclonus syndrome.
    Klein A; Schmitt B; Boltshauser E
    Eur J Pediatr; 2007 Apr; 166(4):359-63. PubMed ID: 17089089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.